Literature DB >> 17499236

Role of cannabinoid CB2 receptors in glucose homeostasis in rats.

Francisco Javier Bermudez-Silva1, Irene Sanchez-Vera, Juan Suárez, Antonia Serrano, Esther Fuentes, Pablo Juan-Pico, Angel Nadal, Fernando Rodríguez de Fonseca.   

Abstract

Here we show that the activation of cannabinoid CB2 receptors improved glucose tolerance after a glucose load. Blockade of cannabinoid CB2 receptors counteracted this effect, leading to glucose intolerance. Since blockade of cannabinoid CB1 receptors mimics the actions of cannabinoid CB2 receptor agonists, we propose that the endocannabinoid system modulates glucose homeostasis through the coordinated actions of cannabinoid CB1 and CB2 receptors. We also describe the presence of both cannabinoid CB1 and CB2 receptor immunoreactivity in rat pancreatic beta- and non-beta-cells, adding the endocrine pancreas to adipose tissue and the liver as potential sites for endocannabinoid regulation of glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499236     DOI: 10.1016/j.ejphar.2007.02.066

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  41 in total

1.  Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels.

Authors:  Christopher J Lynch; Qing Zhou; Show-Ling Shyng; David J Heal; Sharon C Cheetham; Keith Dickinson; Peter Gregory; Michael Firnges; Ulrich Nordheim; Stephanie Goshorn; Dania Reiche; Lechoslaw Turski; Jochen Antel
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-12-13       Impact factor: 4.310

Review 2.  Endocannabinoid system overactivity and the metabolic syndrome: prospects for treatment.

Authors:  Jennifer M Perkins; Stephen N Davis
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

Review 3.  Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Authors:  Robert P Picone; Debra A Kendall
Journal:  Mol Endocrinol       Date:  2015-04-13

Review 4.  Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Authors:  Jun-Ling Han; Hui-Ling Lin
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 5.  Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?

Authors:  Jürg Gertsch
Journal:  Br J Pharmacol       Date:  2017-01-16       Impact factor: 8.739

Review 6.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

7.  Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

Authors:  J Agudo; M Martin; C Roca; M Molas; A S Bura; A Zimmer; F Bosch; R Maldonado
Journal:  Diabetologia       Date:  2010-09-11       Impact factor: 10.122

Review 8.  The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

Authors:  Béla Horváth; Partha Mukhopadhyay; György Haskó; Pál Pacher
Journal:  Am J Pathol       Date:  2011-12-05       Impact factor: 4.307

Review 9.  The endocannabinoid system in obesity and type 2 diabetes.

Authors:  V Di Marzo
Journal:  Diabetologia       Date:  2008-06-18       Impact factor: 10.122

10.  Presence of functional cannabinoid receptors in human endocrine pancreas.

Authors:  F J Bermúdez-Silva; J Suárez; E Baixeras; N Cobo; D Bautista; A L Cuesta-Muñoz; E Fuentes; P Juan-Pico; M J Castro; G Milman; R Mechoulam; A Nadal; F Rodríguez de Fonseca
Journal:  Diabetologia       Date:  2007-12-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.